72 related articles for article (PubMed ID: 28663059)
1. Human IGF-I Eb-peptide induces cell attachment and lamellipodia outspread of metastatic breast carcinoma cells (MDA-MB-231).
Yeh YJ; Lin CM; Chen TT
Exp Cell Res; 2017 Sep; 358(2):199-208. PubMed ID: 28663059
[TBL] [Abstract][Full Text] [Related]
2. Production of bioactive recombinant human Eb-peptide of pro-IGF-I and identification of binding components from the plasma membrane of human breast cancer cells (MDA-MB-231).
Lo JH; Chen TT
Exp Cell Res; 2018 Jan; 362(1):235-243. PubMed ID: 29191552
[TBL] [Abstract][Full Text] [Related]
3. Suppression of growth and cancer-induced angiogenesis of aggressive human breast cancer cells (MDA-MB-231) on the chorioallantoic membrane of developing chicken embryos by E-peptide of pro-IGF-I.
Chen MJ; Chiou PP; Lin P; Lin CM; Siri S; Peck K; Chen TT
J Cell Biochem; 2007 Aug; 101(5):1316-27. PubMed ID: 17286280
[TBL] [Abstract][Full Text] [Related]
4. Development of rainbow trout hepatoma cell lines: effect of pro-IGF-I Ea4-peptide on morphological changes and anchorage-independent growth.
Chen MJ; Chiou PP; Yang BY; Lo HC; Son JK; Hendricks J; Bailey G; Chen TT
In Vitro Cell Dev Biol Anim; 2004; 40(3-4):118-28. PubMed ID: 15311963
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human breast cancer cell (MBA-MD-231) invasion by the Ea4-peptide of rainbow trout pro-IGF-I.
Siri S; Chen MJ; Chen TT
J Cell Biochem; 2006 Dec; 99(5):1363-73. PubMed ID: 16795042
[TBL] [Abstract][Full Text] [Related]
6. Specific cell surface binding sites shared by human Pro-IGF-I Eb-peptides and rainbow trout Pro-IGF-I Ea-4-peptide.
Kuo YH; Chen TT
Gen Comp Endocrinol; 2003 Jun; 132(2):231-40. PubMed ID: 12812770
[TBL] [Abstract][Full Text] [Related]
7. Biological activity of rainbow trout Ea4-peptide of the pro-insulin-like growth factor (pro-IGF)-I on promoting attachment of breast cancer cells (MDA-MB-231) via alpha2- and beta1-integrin.
Siri S; Chen MJ; Chen TT
J Cell Biochem; 2006 Dec; 99(6):1524-35. PubMed ID: 16817231
[TBL] [Abstract][Full Text] [Related]
8. Novel biological activities of the fish pro-IGF-I E-peptides: studies on effects of fish pro-IGF-I E-peptide on morphological change, anchorage-dependent cell division, and invasiveness in tumor cells.
Chen MJ; Kuo YH; Tian XC; Chen TT
Gen Comp Endocrinol; 2002 May; 126(3):342-51. PubMed ID: 12093122
[TBL] [Abstract][Full Text] [Related]
9. Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells.
Sheikh MS; Shao ZM; Hussain A; Clemmons DR; Chen JC; Roberts CT; LeRoith D; Fontana JA
J Cell Physiol; 1993 Jun; 155(3):556-67. PubMed ID: 7684042
[TBL] [Abstract][Full Text] [Related]
10. A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer.
Dunn SE; Ehrlich M; Sharp NJ; Reiss K; Solomon G; Hawkins R; Baserga R; Barrett JC
Cancer Res; 1998 Aug; 58(15):3353-61. PubMed ID: 9699666
[TBL] [Abstract][Full Text] [Related]
11. Trout Ea4- or human Eb-peptide of pro-IGF-I disrupts heart, red blood cell, and vasculature development in zebrafish embryos.
Chun CZ; Tsai HJ; Chen TT
Mol Reprod Dev; 2006 Sep; 73(9):1112-21. PubMed ID: 16807888
[TBL] [Abstract][Full Text] [Related]
12. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
Matà R; Palladino C; Nicolosi ML; Lo Presti AR; Malaguarnera R; Ragusa M; Sciortino D; Morrione A; Maggiolini M; Vella V; Belfiore A
Oncotarget; 2016 Feb; 7(7):7683-700. PubMed ID: 26655502
[TBL] [Abstract][Full Text] [Related]
13. Tissue-type plasminogen activator is upregulated in metastatic breast cancer cells exposed to insulin-like growth factor-I.
Chernicky CL; Yi L; Tan H; Ilan J
Clin Breast Cancer; 2005 Oct; 6(4):340-8. PubMed ID: 16277885
[TBL] [Abstract][Full Text] [Related]
14. Recombinant E-peptides of pro-IGF-I have mitogenic activity.
Tian XC; Chen MJ; Pantschenko AG; Yang TJ; Chen TT
Endocrinology; 1999 Jul; 140(7):3387-90. PubMed ID: 10385437
[TBL] [Abstract][Full Text] [Related]
15. Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer.
Wolf I; Levanon-Cohen S; Bose S; Ligumsky H; Sredni B; Kanety H; Kuro-o M; Karlan B; Kaufman B; Koeffler HP; Rubinek T
Oncogene; 2008 Nov; 27(56):7094-105. PubMed ID: 18762812
[TBL] [Abstract][Full Text] [Related]
16. Microinjecting recombinant rainbow trout Ea4-peptide of pro-IGF-I into zebrafish embryos causes abnormal development in heart, red blood cells, and vasculature.
Chun CZ; Chen TT
Comp Biochem Physiol C Toxicol Pharmacol; 2007 Feb; 145(1):39-44. PubMed ID: 16914384
[TBL] [Abstract][Full Text] [Related]
17. Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines.
Jackson JG; Zhang X; Yoneda T; Yee D
Oncogene; 2001 Nov; 20(50):7318-25. PubMed ID: 11704861
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor receptor expression and function in human breast cancer.
Cullen KJ; Yee D; Sly WS; Perdue J; Hampton B; Lippman ME; Rosen N
Cancer Res; 1990 Jan; 50(1):48-53. PubMed ID: 2152773
[TBL] [Abstract][Full Text] [Related]
19. The expression and characterization of human recombinant proinsulin-like growth factor II and a mutant that is defective in the O-glycosylation of its E domain.
Yang CQ; Zhan X; Hu X; Kondepudi A; Perdue JF
Endocrinology; 1996 Jul; 137(7):2766-73. PubMed ID: 8770896
[TBL] [Abstract][Full Text] [Related]
20. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
